Neuroendocrine Tumor
📧 Sign up to get email alerts when something new happens for Neuroendocrine Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Targeted Alpha-emitter Therapy of PRRT Naïve and Previous PRRT Neuroendocrine Tumor Patients [Phase 2]
A Phase 2 clinical trial from Orano Med LLC is evaluating targeted alpha-emitter therapy for neuroendocrine tumors in PRRT-naïve and previou…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Cabozantinib in High Grade Neuroendocrine Neoplasms [Phase 2]
A Phase 2 clinical trial evaluating cabozantinib in patients with high-grade neuroendocrine neoplasms is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors [Phase 1]
A Phase 1 clinical trial evaluating a gene-modified immune cell therapy after a conditioning regimen for metastatic melanoma and other metas…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors [Phase 2]
Phase 2 clinical trial evaluating the combination of lenvatinib and pembrolizumab for well-differentiated neuroendocrine tumors is currently…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types [Phase 1, Phase 2]
This update reports a Phase 1/2 trial of atezolizumab plus tivozanib in several immunologically cold tumor types, with the study currently s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: Cohort of Well-differentiated Grade 3 Neuroendocrine Digestive Tumors
This entry reports the completion of a clinical trial cohort studying well-differentiated grade 3 neuroendocrine tumors of the digestive tra…
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Telotristat Ethyl for the Treatment of Carcinoid Heart Disease in Patients With Metastatic Neuroendocrine Tumor [Phase 3]
Phase 3 trial update reports results for telotristat ethyl in treating carcinoid heart disease in patients with metastatic neuroendocrine tu…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan [Phase 3]
Phase 3 open-label study evaluating [68Ga]Ga-DOTA-TATE PET imaging in patients with neuroendocrine neoplasms (and healthy volunteers) in Jap…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: TheraSphere Selective Internal Radiation Therapy (SIRT) as Treatment for Neuroendocrine Tumours With Liver Mets [Phase 2]
This Phase 2 clinical trial update reports completion of the evaluation of TheraSphere selective internal radiation therapy for neuroendocri…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Comparison of Adjuvant Treatment With 177Lu-DOTATATE to Best Supportive Care in Patients After Resection of Neuroendocrine Liver Metastases [Phase 2]
Phase 2 trial evaluating adjuvant 177Lu-DOTATATE versus best supportive care after surgical resection of neuroendocrine liver metastases; th…
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: LUTATHERA Injection General Use Result Survey
A completed clinical trial update reports general-use results for Lutathera (lutetium Lu-177 dotatate) injection in somatostatin receptor–po…
-
CLINICAL_TRIALS trial_result · 2025-11-04Clinical Trial Update: A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine Tumors [EARLY_Phase 1]
Early-phase safety study of the radiopharmaceutical 212Pb-VMT-alpha-NET in patients with neuroendocrine tumors is active but not currently r…
-
CLINICAL_TRIALS trial_result · 2025-11-03Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine Tumors [Phase 1]
Phase 1 trial evaluating the addition of Triapine to Lutetium-177 dotatate radioligand therapy for metastatic neuroendocrine tumors; results…
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype. [Phase 1, Phase 2]
A Phase 1/2 trial evaluating BXCL701 in combination with pembrolizumab for metastatic castration-resistant prostate cancer with small cell n…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: A Study Comparing Treatment With Lutetium[177Lu] Oxodotreotide Injection to Octreotide LAR in Patients With GEP-NETs [Phase 3]
A Phase 3 clinical trial compares Lutetium-177Lu oxodotreotide with Octreotide LAR in patients with gastroenteropancreatic neuroendocrine tu…
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: Open-Label Surufatinib in European Patients With NET [Phase 2]
An open-label Phase 2 trial of surufatinib in European patients with neuroendocrine tumors was terminated, with results posted in 2025.
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: Lenvatinib Efficacy in Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 study evaluating lenvatinib for metastatic neuroendocrine tumors has completed. Results were posted on July 24, 2025.
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: 177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry [Phase 2]
This clinical trial update describes a Phase 2 study of individualized dosimetry-based delivery of Lutathera (177Lu-DOTATATE) for neuroendoc…
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: 68-Ga-labeled Octreotide Analogues PET in Duodenal-pancreatic Neuroendocrine Tumours [Phase 2]
Phase 2 clinical trial evaluating 68Ga-labeled octreotide analogue PET imaging in duodenal and pancreatic neuroendocrine tumors. The study s…
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study [Phase 2]
Phase 2 CABATEN trial evaluated cabozantinib in combination with atezolizumab for advanced neuroendocrine neoplasms of the endocrine system.…
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Phase 1 Study of AlphaMedix™ in Adult Subjects With SSTR (+) NET [Phase 1]
A Phase 1 study of AlphaMedix™ in adults with SSTR-positive neuroendocrine tumors was terminated.
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: SUV on 68Ga-DOTATATE PET/CT and Ki-67 Index in Neuro-Endocrine Tumors [Phase 3]
Phase 3 trial evaluating SUV on 68Ga-DOTATATE PET/CT and Ki-67 index in neuroendocrine tumors has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: Sequentiality of Everolimus and STZ-5FU in Advanced Pancreatic Neuroendocrine Tumor [Phase 3]
Phase 3 trial evaluating sequential therapy with Everolimus followed by STZ-5FU in advanced pancreatic neuroendocrine tumors has completed a…
-
CLINICAL_TRIALS trial_result · 2025-05-01Clinical Trial Update: Evaluation of [18F]Fluoroethyl Triazole Labelled [Tyr3]-Octreotate Analogues for the Imaging of Neuroendocrine Tumours. [Phase 1, Phase 2]
Phase 1/2 study evaluating a radiolabeled [Tyr3]-octreotate analogue for PET imaging of neuroendocrine tumors; the trial has completed and r…
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: A Diagnostic Imaging Study of 64Cu-SARTATE Using PET on Patients With Known or Suspected Neuroendocrine Tumors (DISCO) [Phase 2]
Phase 2 diagnostic imaging trial evaluating copper-64 SARTATE for PET imaging in patients with known or suspected neuroendocrine tumors has …